Form 4 for IMNN Imunon, Inc.
Accepted 2025-09-09 00:00:00 ET · period of report 2025-09-06 · accession 0001437749-25-028685 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-09 | 2025-09-06 | IMNN | Lindborg Stacy | Pres, CEO, Dir | M - OptEx | $0.00 | +1,667 | 3,584 | +87% | $0 |
| D | 2025-09-09 | 2025-09-06 | IMNN | Lindborg Stacy | Pres, CEO, Dir | M - OptEx | $0.00 | -1,667 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-06 | M | A | 1,667 | $0.00 | 3,584 | D | — | — | (F1) Acquisition of common stock resulting from vesting of 100% of the restricted stock granted to Ms. Lindborg on September 6, 2024. |
| 2 | Derivative | Restricted Stock | 2025-09-06 | M | D | 1,667 | $0.00 | 0 | D | — · — to — | 1,667 Common Stock | (F2) Each restricted stock share represents a contingent right to receive one share of Imunon, Inc.'s common stock. (F3) On September 6, 2024, Ms. Lindborg received restricted stock representing 1,667 shares (as adjusted for the reverse stock split) subject to a one-year vesting schedule, vesting 100% on the first anniversary of the grant date. As restricted stock shares vest, the vested shares are automatically converted to vested common stock on a one-for-one basis on the vesting date. |